Treatment Outcomes 24 Months after Initiating Short Bedaquiline- or Injectable-Containing Rifampicin-Resistant Tuberculosis Treatment Regimens: A Retrospective Cohort Study in South Africa
Year: 2021
Type: preprint
Study design: Observational Study
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.3927770
Institutions: Department of Health, McGill University, University of Cape Town, Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Stellenbosch University, Médecins Sans Frontières, Médecins Sans Frontières, National Health Laboratory Service, National Institute for Communicable Diseases, University of the Witwatersrand, South African Medical Research Council, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3206759945